Quantcast
Last updated on April 20, 2014 at 7:43 EDT

Latest Gadolinium Stories

2013-01-08 08:29:39

DALLAS, January 8, 2013 /PRNewswire/ -- According to a new market research report "Contrast Media/Contrast Agents Market By Product (Iodinated, Gadolinium and Barium), By Technique (X-ray, CT, MRI, Cath Lab and Ultrasound) and By Application (Radiology, Interventional Radiology and Interventional Cardiology) - Global Trends and Forecast to 2017" analyzes and studies the major market drivers, restraints, opportunities and technology trends in North America, Europe, APAC and Rest...

2012-10-09 04:00:48

The national class action lawyers at Glen Lerner Injury Attorneys announced that they are now reviewing potential gadolinium contrast claims for people with impaired kidneys who underwent a magnetic resonance image (MRI) scan that used a gadolinium contrast agent. These individuals may be at risk for developing Nephrogenic Systemic Fibrosis (NSF). Any individuals that suffer from kidney disease who have been exposed to a Gadolinium MRI contrast agent are encouraged to call 1 (800) GET-GLEN...

2012-05-02 11:42:41

Researchers at Harvard-affiliated McLean Hospital have shown a new category of "green" nanoparticles comprised of a non-toxic, protein-based nanotechnology that can non-invasively cross the blood brain barrier and is capable of transporting various types of drugs. In an article published May 1, 2012 online in PLoS ONE, Gordana Vitaliano, MD, director of the Brain Imaging NaNoTechnology Group at the McLean Hospital Imaging Center, reported that clathrin protein, a ubiquitous protein found...

Novel Radiation Surveillance Technology Could Help Thwart Nuclear Terrorism
2012-05-01 12:32:42

Homeland security Among terrorism scenarios that raise the most concern are attacks involving nuclear devices or materials. For that reason, technology that can effectively detect smuggled radioactive materials is considered vital to U.S. security. To support the nation's nuclear-surveillance capabilities, researchers at the Georgia Tech Research Institute (GTRI) are developing ways to enhance the radiation-detection devices used at ports, border crossings, airports and elsewhere. The...

2012-02-14 10:00:00

RALEIGH, N.C., Feb. 14, 2012 /PRNewswire/ -- Viztek, the digital imaging solution provider, announced today the launch of the ViZion DR Rad Room Straight Arm. The DR solution, exclusively sold from Viztek is ideal for various settings that require a low cost and space-saving solution; the ViZion DR Straight Arm offers superior image quality, available PACS integration, and access to Viztek's front-end software. The complete ViZion DR Rad Room package includes a 17x17 Gadolinium...

2011-06-29 07:00:00

CAGE Chemicals, University of Turin and Aspect Imaging to Develop Applications and Products for Molecular Imaging on Aspect's M2(TM) Compact MRI System for Preclinical Imaging TORONTO, Canada, SHOHAM, Israel, and TURIN, Italy, June 29, 2011 /PRNewswire/ - Aspect Imaging today announced its agreement with CAGE Chemicals to develop and manufacture Aspect's PhenoQuant(TM) line of contrast agents for preclinical research. A third contributor in the partnership, University of Turin's...

2011-05-18 06:54:05

(Ivanhoe Newswire) -- A simple blood test may help prevent a serious complication associated with a contrast agent commonly used in MRI exams. Within the past five years, use of gadolinium-based contrast agents (GBCA) has been linked to the development of nephrogenic systemic fibrosis (NSF), a rare disorder mainly affecting patients with severe kidney disease. But since 2008, restrictive GBCA administration guidelines implemented by Massachusetts General Hospital have proven effective in...

2011-05-03 13:36:01

A recent study shows how one medical center implemented strict protocols for administering gadolinium-based contrast agents (GBCAs) before imaging and eliminated new cases for nephrogenic system fibrosis (NSF). Implementing this protocol is particularly important for patients with diminished kidney function says Dr. Ozden Narin, presenting author for this study. "In the past, we had some patients who developed NSF after they were given a gadolinium-based agent before imaging. We implemented...

2011-03-15 09:45:00

SILVER SPRING, Md., March 15, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration approved Gadavist (gadobutrol), a gadolinium-based contrast agent, for use in patients undergoing magnetic resonance imaging (MRI) of the central nervous system. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Gadavist was approved by the FDA on March 14. It provides contrast-enhanced imaging of the central nervous system, helping to detect and visualize lesions that disrupt the...

2011-02-01 16:53:22

The work could lead to improved methodologies for creating materials by design Scientists have given us a plethora of new materials "“ all created by combining individual elements under varying temperatures and other conditions. But to tweak an intermetallic compound even more, in order to give it the attributes you desire, you have to go deeper and re-arrange individual atoms. It's a process similar to what bioengineers employ when they add and delete genes to create synthetic...